Sunitinib Malate 37.5 mg/1

Sunitinib Malate 37.5 mg capsules are a medication used for targeted therapy. This oral treatment is designed to inhibit specific proteins involved in cancer cell growth.

Sunitinib Malate is primarily used in the treatment of certain types of cancer. It works by targeting proteins that help cancer cells grow and spread. This medication is often prescribed for advanced or metastatic cancers, including renal cell carcinoma and gastrointestinal stromal tumors. Patients should consult their healthcare provider to understand the specific uses of Sunitinib Malate for their condition.

Common effects of Sunitinib Malate may include fatigue, nausea, and diarrhea. Some patients may experience skin discoloration or hand-foot syndrome, characterized by redness and swelling on the palms and soles. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Sunitinib Malate should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should avoid activities that require alertness if they experience drowsiness. Regular blood tests may be necessary to monitor for potential side effects.

Sunitinib Malate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform healthcare providers about all medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.